Journal of Antimicrobial Chemotherapy (2002) 49, 661-666
© 2002 The British Society for Antimicrobial Chemotherapy
Antimicrobial practice |
Antibiotic guidelines and antibiotic use in adult bacterial meningitis in The Netherlands
Department of Neurology and The Netherlands Reference Laboratory for Bacterial Meningitis/Department of Medical Microbiology, Academic Medical Centre, PO Box 22660, 1100 DD Amsterdam, The Netherlands
In The Netherlands, national guidelines for the treatment of adult patients with bacterial meningitis were introduced in October 1997. In 1998 we began a prospective, nationwide study to evaluate the compliance with these consensus-based guidelines. In addition, we evaluated whether the recommended initial treatment provides adequate microbiological coverage. From October 1998 to January 2000, 365 adults with bacterial meningitis were identified using information from The Netherlands Reference Laboratory for Bacterial Meningitis; 263 patients were classified into four categories depending on patient's age and underlying health status. In the first category, patients 16–60 years without risk factors, Neisseria meningitidis was the most common pathogen (53%); 62 of 127 patients (49%) received treatment in compliance with the guidelines. In the second and third categories, patients >60 years without risk factors and those with risk factors independently of age, Streptococcus pneumoniae caused 61% and 58% of cases, respectively. Compliance in these categories was about 17%. Overall, 33% of patients received treatment in compliance with the guidelines. The microbiological coverage of patients treated in compliance and not in compliance with the guidelines was 98% and 93%, respectively. In conclusion, 1 year after national consensus-based guidelines for the initial treatment of adult patient with bacterial meningitis were introduced in The Netherlands, only one-third of Dutch physicians were adhering to the guidelines. The microbiological coverage for the patients who were treated in compliance with the guidelines was almost complete (98%).
* Corresponding author. Tel: +31-20-5663842; Fax: +31-20-6971438; E-mail: D.vandeBeek{at}amc.uva.nl
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. S Schut, J. de Gans, and D. van de Beek Community-acquired bacterial meningitis in adults Practical Neurology, January 1, 2008; 8(1): 8 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. van de Beek, J. de Gans, A. R. Tunkel, and E. F.M. Wijdicks Community-Acquired Bacterial Meningitis in Adults N. Engl. J. Med., January 5, 2006; 354(1): 44 - 53. [Full Text] [PDF]
|
|
|
|
 |
|
 C. MacDougall and R. E. Polk Antimicrobial Stewardship Programs in Health Care Systems Clin. Microbiol. Rev., October 1, 2005; 18(4): 638 - 656. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. G. M. Mol, J. E. Wieringa, P. V. NannanPanday, R. O. B. Gans, J. E. Degener, M. Laseur, and F. M. Haaijer-Ruskamp Improving compliance with hospital antibiotic guidelines: a time-series intervention analysis J. Antimicrob. Chemother., April 1, 2005; 55(4): 550 - 557. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. van de Beek, J. de Gans, L. Spanjaard, M. Weisfelt, J. B. Reitsma, and M. Vermeulen Clinical Features and Prognostic Factors in Adults with Bacterial Meningitis N. Engl. J. Med., October 28, 2004; 351(18): 1849 - 1859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Cohen Management of bacterial meningitis in adults BMJ, May 10, 2003; 326(7397): 996 - 997. [Full Text] [PDF]
|
|
|
|
|
|
J. de Gans, D. van de Beek, and the European Dexamethasone in Adulthood Bacterial Dexamethasone in Adults with Bacterial Meningitis N. Engl. J. Med., November 14, 2002; 347(20): 1549 - 1556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Brown Guidelines for antibiotic usage in hospitals J. Antimicrob. Chemother., April 1, 2002; 49(4): 587 - 592. [Full Text] [PDF]
|
|